Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Mirus Bio™ TransIT™-BrCa Transfection Reagent
Dedicated breast-cancer-cell-line-specific reagent. Delivers efficiently to many breast cancer cell types and maintains low cellular toxicity. Transfection with TransIT™-BrCa Reagent does not require medium changes and can be performed in serum-containing medium.
Supplier: Mirus Bio™ MIR5500
Description
- Broad spectrum DNA delivery: Achieve high expression levels in breast cancer cell types including MCF-7, MDA-MB-231, MDA-MB-453, MDA-MB-468 and T47D
- Formulated for low cellular toxicity: Maintain cell density and reduce experimental biases due to toxicity
- Multiple applications: Transient and stable transfections for gene expression, shRNA expression and promoter analyses
Specifications
| Cancer Cells | |
| None (Promoterless) | |
| Achieve high expression levels in breast cancer cell types including MCF-7, MDA-MB-231, MDA-MB-453, MDA-MB-468 and T47D, transient and stable transfections for gene expression, shRNA expression and promoter analyses | |
| 1 mL |
| Tube | |
| Chemical Transfection | |
| Transfection Reagent | |
| Sterile |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction